Related Experiment Video

Updated: May 28, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

British National Formulary for Children: the risk of inappropriate paracetamol prescribing

Sally Eyers1, James Fingleton, Ashley Eastwood

  • 1Medical Research Institute of New Zealand, Private Bag 7902, Newtown, Wellington 6242, New Zealand. sally.eyers@mrinz.ac.nz

Archives of Disease in Childhood
|October 4, 2011
PubMed

Insights

Age-based dosing for paracetamol in children can lead to incorrect dosages. Underweight and overweight children may receive unsafe amounts of paracetamol (acetaminophen) based on current guidelines.

Area of Science:

  • Pediatric pharmacology
  • Drug safety and efficacy
  • Evidence-based medicine

Background:

  • Paracetamol (acetaminophen) is a widely used medication for children.
  • Current age-based dosing guidelines may not account for individual weight variations.

Purpose of the Study:

  • To evaluate the appropriateness of age-based paracetamol dosing in children.
  • To identify potential risks associated with current dosing recommendations.

Main Methods:

  • Analysis of age-based paracetamol dosing in the British National Formulary for Children (BNFC) 2011-2012.
  • Calculation of single and cumulative doses for various weight centiles (9th, 50th, 91st) across different age groups.

Main Results:

  • Children at the 9th weight centile (underweight) may receive doses exceeding therapeutic limits.
  • Children at the 91st weight centile (overweight) may receive doses below therapeutic limits.

Conclusions:

  • Age-based paracetamol dosing poses a risk of under- or overdosing for children with non-standard weights.
  • Weight-based dosing adjustments are crucial for safe and effective paracetamol administration in pediatric populations.
Abstract

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...